SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-13-003756
Filing Date
2013-01-04
Accepted
2013-01-04 16:07:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 ON FORM S-3 d460806dposam.htm POS AM 250561
2 CONSENT OF MCGLADREY LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. d460806dex231.htm EX-23.1 1762
3 GRAPHIC g460806cov_001.jpg GRAPHIC 8631
  Complete submission text file 0001193125-13-003756.txt   265432
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-169463 | Film No.: 13511823
SIC: 2834 Pharmaceutical Preparations